✨ Your Portfolio is fetched and updated from zerodha.
Micro Miscellaneous

Dipna Pharmachem Ltd.

DPL

Market Cap
₹44 Cr.
P/E
40.21

Dipna Pharmachem Ltd.

  • Dipna Pharma.
  • Deccan Health Care
  • JFL Life Sciences
FAQs on Dipna Pharmachem Ltd. Shareprice

Dipna Pharma. has given better returns compared to its competitors.
Dipna Pharma. has grown at ~11.71% over the last 2yrs while peers have grown at a median rate of 6.9%

Dipna Pharma. is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA.
Latest PE of Dipna Pharma. is 40.21, while 3 year average PE is 22.08.
Also latest EV/EBITDA of Dipna Pharma. is 0 while 3yr average is 8.74.

View FAQ's On Business
Growth Table
  • Dipna Pharmachem Ltd.
  • Deccan Health Care
  • JFL Life Sciences
Balance Sheet
  • Dipna Pharmachem Ltd.
  • Deccan Health Care
  • JFL Life Sciences
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Dipna Pharmachem Ltd.
  • Deccan Health Care
  • JFL Life Sciences
Cash Flow
  • Dipna Pharmachem Ltd.
  • Deccan Health Care
  • JFL Life Sciences
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Dipna Pharmachem Ltd.
  • Deccan Health Care
  • JFL Life Sciences
Quarterly Results
  • Dipna Pharmachem Ltd.
  • Deccan Health Care
  • JFL Life Sciences
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Dipna Pharmachem Ltd. Financials

Balance sheet of Dipna Pharma. is moderately strong.

Yes, The debt of Dipna Pharma. is increasing.
Latest debt of Dipna Pharma. is ₹17.04 Crs as of Sep-24.
This is greater than Mar-24 when it was -₹8.3 Crs.

The profit is oscillating.
The profit of Dipna Pharma. is ₹0.83 Crs for TTM, ₹1.09 Crs for Mar 2024 and ₹0.91 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Dipna Pharma. latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Inventory, Short Term Loans & Advances

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech